Abstract
BACKGROUND: People who have diabetes may have a range of psychological disorders as a result of their condition. Diabetes distress (DD) is one such psychological condition. DD is a serious issue that is accompanied by emotional problems, stress, guilt, and treatment avoidance. Type II diabetes mellitus patients are more likely to experience it. Around 45% of people have DD worldwide, which is fairly significant because it can predict clinical outcomes in T2DM patients. Among diabetic patients, poor self-care, poor self-management, and lower treatment adherence are some of the unfavorable treatment outcomes connected to DD. Depression is a mental illness marked by a depressive mood, a lack of activity, and a negative sense of inadequacy. It typically develops as the severity of the distress increases because chronic anguish can sometimes develop from recurrent, poorly managed discomfort. Depression is therefore a noted common component and regularly co-occurs in diabetic individuals.
AIM: The aim of the present study is to Study the Impact of Depression on Treatment Compliance in Patients with Type II Diabetes Mellitus.
MATERIAL AND METHOD: The Department of Psychiatry undertook this cross-sectional observational study. The director of the department of diabetesology gave us permission. The study participants' privacy and confidentiality were protected. They gave us their written consent once we informed them. Consultative physicians initially identified T2DM in patients after analyzing them using diagnostic tests from reputable laboratories. The Morisky Medication Adherence Questionnaire and Hospital Anxiety and Depression Scales were used to measure medication adherence and anxiety and depression, respectively. The primary investigator also collected data using a proforma to gather baseline information on patients, a 24-hour diet survey, and exercise information. 80 was the estimated sample size. We determined the sample sizes for the two main goals and chose the larger one.
RESULTS: The sample size achieved was 80. Participants in the study had an interquartile range of 54 to 65 and a median age of Sixty. 80 people in all took part in the survey, of which 34% were men, 70% were married, 40% had education beyond high school, and 52% of men and 40% of women were employed. Among all (80), 52% had been under follow-up for Diabetes for more than eight years. All had been taking oral hypoglycemic agents and 4% were taking Inj. Insulin additionally for glycemic control; seventy-one percent had one or more physical comorbidities along with type II DM, among which 86.2% had hypertension.
CONCLUSION: Preventing, recognizing, and treating health issues is crucial for a healthy society. The World Health Organization cautions us, however, that there is "a significant gap between the burden caused by mental diseases and the resources available to prevent and cure them. According to estimates, four out of five individuals with major mental illnesses who reside in low- and middle-income nations do not have access to the mental health care they require. Depression in diabetic patients is still underdiagnosed, so it's crucial for the diabetic specialist to be aware of this rather typical co-morbidity.
KEYWORDS: Depression; Quality of life; Compliance; Diabetes, Type II DM, Anxiety.